NKTR
Nektar Therapeutics
43.60$
-7.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.0% | -0.5% | -13.3% | -10.3% | -1.3% | -15.7% | -19.0% | +45.2% | -6.9% | +172.2% | +43.5% | |
| – | -17.1% | -3.3% | -7.7% | -2.9% | -8.8% | -12.0% | -18.9% | +50.8% | -5.4% | +121.2% | +25.5% | |
| – | -45.7% | +37.9% | -71.4% | +116.3% | +47.0% | -12.1% | +10.5% | -4.6% | -63.2% | +772.4% | -70.3% | |
| – | -18.5% | -4.7% | -6.2% | -9.9% | +4.4% | -14.3% | -19.5% | +53.6% | -9.1% | +131.4% | +20.4% | |
| – | -34.3% | +141.3% | -46.6% | -26.8% | -24.2% | +6.5% | -21.2% | -4.6% | +38.0% | +102.4% | +32.1% | |
| – | +6.4% | +0.9% | -10.9% | -100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -5.6% | +0.8% | -2.1% | -1.7% | -6.2% | -0.3% | -4.4% | -6.7% | -11.9% | -1.8% | +2.6% | |
| – | -1.6% | +2.2% | +9.4% | +17.9% | -9.1% | +15.5% | +0.6% | -7.1% | -19.3% | +7.8% | +23.0% | |
| – | +0.9% | +0.6% | +10.2% | +0.8% | -7.6% | +9.9% | +0.8% | +0.8% | -7.6% | +9.9% | +0.8% | |
| – | +199.5% | -11.1% | -26.1% | +32.5% | +34.8% | +54.3% | -19.9% | +9.0% | -30.8% | -6.9% | +148.3% | |
| – | -17.8% | -3.3% | -37.1% | -38.7% | +24.2% | -77.4% | -276.2% | – | +5.6% | +541.4% | +56.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | +1.9% | +7.2% | +0.2% | +2.1% | -1.3% | +0.2% | +0.0% | +44.1% | +21.9% | +33.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.